Identification and Characterization of Cell Autonomous Determinants that Promote
$245,642U54FY2012CANIH
Beth Israel Deaconess Medical Center, Boston MA
Investigators
Linked publications & trials
Paper 36750562Paper 34719426Paper 31279774Paper 30065048Paper 26595531Paper 26560028Paper 26521296Paper 25704811Paper 25660025Paper 25446899Paper 25215489Paper 25111226Paper 25049013Paper 24856586Paper 24679525Paper 24162813Paper 23817022Paper 23353556Paper 23255577Paper 22306733Paper 22264789
Abstract
The Pandolfi laboratory proposes to investigate cell autonomous genetic and cell biological factors that influence the metastatic potential of prostate cancer (CaP) cells. Specifically, we will determine whether certain genetic mutations associated with CaP development confer metastatic capacity onto otherwise non-metastatic cells or increase a tumor cell subpopulation with intrinsic propensity to metastasis. Furthermore, we will perform an in vivo screen to probe for genes that, when deregulated, promote prostate cancer metastasis. We will use the gained information to refine and improve existing CaP mouse models utilized in basic cancer biology and preclinical drug evaluation efforts.
View original record on NIH RePORTER →